butyrylcholinesterase deficiency
butyrylcholinesterase deficiency
Explore linked clinical trials. Standard reference: MONDO:00152702 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab | Diabetes Complications, Embolism and Thrombosis, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Venous Thrombosis, butyrylcholinesterase deficiency, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, glucose metabolism disease, macular degeneration, metabolic disease, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Recruiting | Not stated | 2026-04-24 | NCT07550777 | |
| The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA) | Arrhythmias, Cardiac, Chemically-Induced Disorders, Chronic Pain, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Muscle Hypotonia, Myotoxicity, Neurologic Manifestations, Neuromuscular Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Succinylcholine Sensitivity, Urogenital Diseases, acute kidney injury, butyrylcholinesterase deficiency, cardiovascular disorder, heart disorder, injury, kidney disorder, kidney failure, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, radiation injury, urinary system disorder | Recruiting | Not applicable | 2024-11-27 | NCT06707532 |